P

Plus Therapeutics

D

PSTV

USD

-0.049

(-2.9715%)

Market Closed

545.00

حجم التداول

-2.22

الربح لكل سهم

-

العائد الربحي

-0.504854

P/E

9,434,132.80

حجم السوق

اليوم

-2.9715%

1 اسبوع

11.888%

1 شهر

0.000%

6 اشهر

-12.568%

12 اشهر

25.984%

بداية السنة

-8.577%

كل الوقت

0%

أصول ذات صلة

Title:
Plus Therapeutics

Sector:

Healthcare

Industry:

Biotechnology

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا